Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad H Ghalib

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Molecular Cancer Research : MCR|October 6, 2012
Reovirus: a targeted therapeutic--progress and potentialRadhashree Maitra, Mohammad H Ghalib, Sanjay Goel
Critical Reviews in Oncology/Hematology|April 16, 2011
Eribulin -- a review of preclinical and clinical studiesUmang Swami, Imran Chaudhary, Mohammad H Ghalib, et al.
JAMA Network Open|July 11, 2024
Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials: A Meta-AnalysisSanjay Goel, Abdissa Negassa, Mohammad H Ghalib, et al.
Molecular Cancer Therapeutics|March 12, 2020
Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with <i>KRAS</i>-Mutated Colorectal CancerSanjay Goel, Allyson J Ocean, Ruwan Y Parakrama, et al.
Investigational New Drugs|October 14, 2018
Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trialsAudrey E Kam, Gopichand Pendurti, Umang H Shah, et al.
Investigational New Drugs|July 3, 2009
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumorsRadharani Gollamudi, Mohammad H Ghalib, Kavita K Desai, et al.
Clinical Colorectal Cancer|April 17, 2017
Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities With Metastatic Colorectal CancerSanjay Goel, Abdissa Negassa, Ashish Khot, et al.
Investigational New Drugs|August 3, 2024
A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumorsMohammad H Ghalib, Mariano Provencio Pulla, Maria J De Miguel Luken, et al.
Investigational New Drugs|November 26, 2013
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumorsSharad Ghamande, Chia-Chi Lin, Daniel C Cho, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Cancer Research : MCR|October 6, 2012
Reovirus: a targeted therapeutic--progress and potentialRadhashree Maitra, Mohammad H Ghalib, Sanjay Goel
Critical Reviews in Oncology/Hematology|April 16, 2011
Eribulin -- a review of preclinical and clinical studiesUmang Swami, Imran Chaudhary, Mohammad H Ghalib, et al.
JAMA Network Open|July 11, 2024
Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials: A Meta-AnalysisSanjay Goel, Abdissa Negassa, Mohammad H Ghalib, et al.
Molecular Cancer Therapeutics|March 12, 2020
Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with <i>KRAS</i>-Mutated Colorectal CancerSanjay Goel, Allyson J Ocean, Ruwan Y Parakrama, et al.
Investigational New Drugs|October 14, 2018
Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trialsAudrey E Kam, Gopichand Pendurti, Umang H Shah, et al.
Investigational New Drugs|July 3, 2009
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumorsRadharani Gollamudi, Mohammad H Ghalib, Kavita K Desai, et al.
Clinical Colorectal Cancer|April 17, 2017
Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities With Metastatic Colorectal CancerSanjay Goel, Abdissa Negassa, Ashish Khot, et al.
Investigational New Drugs|August 3, 2024
A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumorsMohammad H Ghalib, Mariano Provencio Pulla, Maria J De Miguel Luken, et al.
Investigational New Drugs|November 26, 2013
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumorsSharad Ghamande, Chia-Chi Lin, Daniel C Cho, et al.
Pageof 1